New blood test detects stroke and heart attack risk in lupus patients with no CVD symptoms

June 15, 2017, European League Against Rheumatism

The results of a study presented today at the Annual European Congress of Rheumatology (EULAR) 2017 press conference have shown that a specific biomarker detected in the blood of lupus patients with no symptoms of cardiovascular disease (CVD), thought to be at low risk of CVD based on traditional risk factors, is associated with the presence of atherosclerosis .

Overall, the risk of having fatty deposits (plaques) in the arteries that deliver blood to the brain due to atherosclerosis was increased by a factor of 8 times in those who had a biomarker known as High Sensitivity Cardiac Troponin T (HS-cTnT) in their blood.1

Premature CVD is much more common in young premenopausal women with lupus than healthy women of a similar age. With the increased life expectancy of lupus patients due to improved therapy, CVD has emerged as a significant threat to their health.2 CVD is a major cause of death and ill-health in lupus patients. Using traditional risk factors as the 'Framingham score' has previously underestimated the risk of CVD in this population.

"The results of our study raise the possibility that this easily measured biomarker could be introduced into clinical practice as a more reliable way of evaluating CVD risk in lupus patients," said lead author Dr. Karim Sacre, from the Bichat Hospital, Paris, France. "This in turn will enable more effective primary prevention measures such as treating abnormally raised blood lipids to be implemented," he added.

Using vascular ultrasound, 23 out of 63 (36.5%) consecutive lupus patients were found to have signs of carotid plaques compared to only 2 out of 18 (11.1%) of a control group. None of these patients nor the controls had symptoms of CVD and they all had a low Framingham risk factor score. Only age (p=0.006) and lupus disease status (p=0.017) were independently associated with the presence of carotid plaques.

The percentage of lupus patients with carotid plaques who had a detectable HS-cTnT was 87%; only 42.5% of lupus patients without plaques had a detectable level of HS-cTnT (p<0.001). Conversely, 54.5% of lupus patients with a detectable HS-cTnT, but only 11.5% with an undetectable HS-cTnT had a carotid (p<0.001).

"Before introducing this new biomarker into clinical practice, we are conducting further research to confirm our findings on a larger cohort of patients, with a longer follow up period, analysing not only carotid plaques, but also the occurrence of major cardiovascular events," Dr. Sacre concluded.

Lupus (Systemic Lupus Erythematosus) is a genetically complex chronic relapsing immune mediated rheumatic disease characterised by inflammation that may affect different tissues, including the skin, joint linings, lungs, kidneys and other organs. Lupus predominately affects women, occurring 10 times more often than in men, and frequently starting at child-bearing age. The disease is highly variable in the way it may present, and in its outcome among individuals and across different ancestral groups.

Explore further: Previous bacterial infection increases risk of newly-diagnosed Sjogren's syndrome syndrome

Related Stories

Previous bacterial infection increases risk of newly-diagnosed Sjogren's syndrome syndrome

June 15, 2017
The results of a study presented today at the Annual European Congress of Rheumatology (EULAR) 2017 have shown a link between newly-diagnosed Sjögren's syndrome (SjS) and previous infection with nontuberculous mycobacteria ...

Investigating kidney biomarkers to track lupus

December 16, 2016
Lupus, a chronic autoimmune disease, can wreak havoc on an affected individual's body through inflammation, pain and even damage of the skin, joints and organs.

Low vitamin D levels linked to lupus

April 30, 2015
Monash-led research has shown for the first time that low vitamin D levels are associated with higher disease activity in Australian lupus patients.

Lower mortality rates among Asian and Hispanic lupus patients

January 15, 2015
A new study by researchers from Brigham and Women's Hospital in Boston, Massachusetts reveals that Asian and Hispanic patients with systemic lupus erythematosus (SLE) have lower mortality rates compared to Black, White, or ...

Lupus may contribute to pregnancy-related complications

February 1, 2016
A new study found that lupus during pregnancy may have negative health impacts for women and their babies. The study included 13,598 Swedish women in their first pregnancy, and all were singleton pregnancies. Preeclampsia, ...

Study identifies biomarker linked to poor outcomes in pregnant lupus patients

October 28, 2013
Researchers at Hospital for Special Surgery in New York City have identified a biomarker that may predict poor pregnancy outcomes in lupus patients.

Recommended for you

Biomechanical mapping method aids development of therapies for damaged heart tissue

January 23, 2018
Researchers have developed a new way to capture the detailed biomechanical properties of heart tissue. The high-resolution optical technique fills an important technology gap necessary to develop and test therapies that might ...

Researchers borrow from AIDS playbook to tackle rheumatic heart disease

January 22, 2018
Billions of US taxpayer dollars have been invested in Africa over the past 15 years to improve care for millions suffering from the HIV/AIDS epidemic; yet health systems on the continent continue to struggle. What if the ...

Improving vaccines for the elderly by blocking inflammation

January 22, 2018
By identifying why skin immunity declines in old age, a UCL-led research team has found that an anti-inflammatory pill could help make vaccines more effective for elderly people.

Novel genomic tools provide new insight into human immune system

January 19, 2018
When the body is under attack from pathogens, the immune system marshals a diverse collection of immune cells to work together in a tightly orchestrated process and defend the host against the intruders. For many decades, ...

A nanoparticle inhalant for treating heart disease

January 18, 2018
A team of researchers from Italy and Germany has developed a nanoparticle inhalant for treating people suffering from heart disease. In their paper published in the journal Science Translational Medicine, the group describes ...

First vaccine developed against grass pollen allergy

January 18, 2018
Around 400 million people worldwide suffer in some form or other from a grass pollen allergy (rhinitis), with the usual symptoms of runny nose, cough and severe breathing problems. In collaboration with the Viennese firm ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.